Realtimekurse aktiv
Tradegate
27.03.25
16:50 Uhr
2,440 Euro
-0,120
-4,69 %
-4,69 %
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,580 | 2,620 | 20:14 | |
| 2,580 | 2,620 | 19:56 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
|---|---|---|---|---|
| Mo | Savara: Loan & Security Agreement Signed For Up To $200 Million With Hercules Capital | 4 | pulse2.com | |
| SAVARA Aktie jetzt für 0€ handeln | ||||
| Fr | Savara stock holds Buy rating, $6 target from H.C. Wainwright | 1 | Investing.com | |
| Do | Savara Inc Q4 Loss Increases, Misses Estimates | 1 | RTTNews | |
| Do | Savara Inc - 10-K, Annual Report | 1 | SEC Filings | |
| Do | Savara GAAP EPS of -$0.13 | 1 | Seeking Alpha | |
| Do | JMP maintains $9 target on Savara stock, sees FDA nod | 1 | Investing.com | |
| Mi | Savara secures $200M loan to support respiratory drug launch | 6 | Investing.com | |
| Mi | Savara Inc - 8-K, Current Report | 3 | SEC Filings | |
| Mi | Savara submits FDA application for aPAP therapy MOLBREEVI | 2 | Investing.com | |
| 06.03. | Savara Launches New Dried Blood Spot Test For APAP Diagnosis | 2 | RTTNews | |
| 23.01. | Savara Inc - 8-K, Current Report | - | SEC Filings | |
| 13.01. | Savara Inc - 8-K, Current Report | 2 | SEC Filings | |
| 20.12.24 | Savara (NASDAQ:SVRA) Now Covered by Analysts at Wells Fargo & Company | 3 | MarketBeat | |
| 20.11.24 | Savara-Direktor Joseph McCracken erwirbt Stammaktien im Wert von 59.071 US-Dollar | 4 | Investing.com Deutsch | |
| 18.11.24 | Savara Inc. Direktor David Ramsay kauft Stammaktien im Wert von 287.600 US-Dollar | 8 | Investing.com Deutsch | |
| 14.11.24 | Savara (NASDAQ:SVRA) Sets New 12-Month Low Following Analyst Downgrade | 2 | MarketBeat | |
| 13.11.24 | Savara downgraded at Evercore on manufacturing concerns for lung disease candidate | 2 | Seeking Alpha | |
| 12.11.24 | Savara Reports Third Quarter 2024 Financial Results and Provides Business Update | 175 | Business Wire | |
| 22.10.24 | Savara sponsors Lifetime talk show episode about rare respiratory disease ahead of FDA submission | 2 | FiercePharma | |
| 08.10.24 | Savara stock outlook steady as H.C. Wainwright highlights challenges in doctor engagement at CHEST meeting | 2 | Investing.com |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
Das Unternehmen SAVARA INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 2,440 Euro und damit -4,69 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SAVARA INC finden Sie auf Wallstreet Online.
